Return to all milestones

COVID-19 vaccine production disrupts supply chain

1 billion COVID-19 vaccines have been produced to date. But manufacturing them at the volume the world needs - while maintaining the production of vaccines and medicines for other diseases - is a colossal challenge. The movement of specialized, skilled personnel is able to ensure the highest level of quality. But this scaling up of manufacturing in record time leads to shortages This link will open in a new window of raw materials and equipment such vials, needles and syringes, impacting the entire vaccine supply chain.

The World Trade Organization This link will open in a new window stresses the need to strengthen global vaccine roll-out, calling on countries to allow the free flow of medical goods and address trade barriers by removing supply bottlenecks.

India imposes a ban This link will open in a new window on COVID-19 vaccine exports to prioritize the country's needs, amid a new wave of infections. This impacts exports from the Serum Institute of India for months This link will open in a new window, with the ban only being lifted in October 2021.

Johnson & Johnson announces This link will open in a new window an advance purchase agreement with the African Vaccine Acquisition Trust for the company's COVID-19 vaccine.

GSK signs an agreement This link will open in a new window with Novavax and the UK Government Vaccine Taskforce to support the manufacturing of up to 60 million doses of Novavax's COVID-19 vaccine.

Over 1 million SARS-CoV-2 sequences have been shared on GISAID This link will open in a new window, supporting expanded pathogen and disease surveillance and allowing scientists to monitor the virus's evolution.

COVAX deliveries This link will open in a new window reach over 100 countries, 42 days after the first international delivery.

In the space of four months, 1 billion doses of COVID-19 vaccines This link will open in a new window have been administered around the world.

The WHO This link will open in a new window authorizes Moderna's COVID-19 vaccine for emergency use.

During the second Global COVID-19 Summit, Pfizer commits to solve vaccine distribution challenges This link will open in a new window by expanding its partnerships with UPS Foundation and Zipline to help to deliver millions of its COVID-19 vaccine doses to African vaccination centers and remote areas.

CEPI, IFPMA, DCVMN, and partners in the COVAX Facility announce the COVAX Manufacturing Task Force This link will open in a new window to support the establishment or upgrading of vaccine manufacturing facilities.